Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Sell
32,246
-2,147
-6% -$903K ﹤0.01% 1445
2026
Q1
$13M Buy
34,393
+101
+0.3% +$43.3K ﹤0.01% 1404
2025
Q4
$14.7M Buy
34,292
+1,622
+5% +$706K ﹤0.01% 1328
2025
Q3
$14.6M Sell
32,670
-15,772
-33% -$7.14M ﹤0.01% 1335
2025
Q2
$23.6M Sell
48,442
-1,169
-2% -$666K 0.01% 993
2025
Q1
$30.5M Buy
49,611
+10,160
+26% +$5.77M 0.01% 868
2024
Q4
$20.9M Buy
39,451
+6,005
+18% +$3.39M 0.01% 1167
2024
Q3
$20.1M Sell
33,446
-310
-0.9% -$176K 0.01% 1194
2024
Q2
$18.3M Sell
33,756
-1,845
-5% -$1.06M 0.01% 1193
2024
Q1
$22.9M Sell
35,601
-697
-2% -$423K 0.01% 1103
2023
Q4
$21.2M Buy
36,298
+1,003
+3% +$561K 0.01% 1120
2023
Q3
$18.3M Sell
35,295
-419
-1% -$218K 0.01% 1092
2023
Q2
$19.3M Sell
35,714
-2,198
-6% -$1.2M 0.01% 1087
2023
Q1
$20.4M Buy
37,912
+218
+0.6% +$111K 0.01% 1033
2022
Q4
$19.2M Buy
37,694
+892
+2% +$434K 0.01% 1064
2022
Q3
$16.1M Sell
36,802
-1,593
-4% -$766K 0.01% 1165
2022
Q2
$18M Sell
38,395
-1,254
-3% -$612K 0.01% 1110
2022
Q1
$19.3M Sell
39,649
-140
-0.4% -$67.1K 0.01% 1215
2021
Q4
$21.1M Sell
39,789
-6,122
-13% -$2.94M 0.01% 1204
2021
Q3
$21.4M Sell
45,911
-9,457
-17% -$4.46M 0.01% 1228
2021
Q2
$26.3M Sell
55,368
-18,483
-25% -$8.88M 0.01% 1161
2021
Q1
$34M Sell
73,851
-3,741
-5% -$1.83M 0.01% 954
2020
Q4
$41.3M Buy
77,592
+13,401
+21% +$6.58M 0.01% 804
2020
Q3
$30.8M Buy
64,191
+8,709
+16% +$4.27M 0.01% 809
2020
Q2
$25M Sell
55,482
-9,608
-15% -$4.29M 0.01% 900
2020
Q1
$28.2M Sell
65,090
-1,951
-3% -$871K 0.01% 716
2019
Q4
$29.4M Sell
67,041
-3,694
-5% -$1.55M 0.01% 949
2019
Q3
$29.5M Sell
70,735
-2,078
-3% -$848K 0.01% 930
2019
Q2
$26.3M Buy
+72,813
New +$24.3M 0.01% 999

Other funds holding CHE

Nuveen's CHE Position: Q2 2026 in Review

Nuveen reduced its Chemed (CHE) stake by 6.2% in Q2 2026, selling an estimated $903K and leaving 32,246 shares worth $15M. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Nuveen first reported a position in CHE in Q2 2019 and has held it in 29 quarters since. The position peaked at $41.3M in Q4 2020. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Nuveen held 32,246 shares of Chemed worth $15M as of Q2 2026.
  • Nuveen sold 2,147 Chemed shares in Q2 2026, an estimated $903K.
  • Chemed made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1445 holding.
  • Nuveen first reported a position in Chemed in Q2 2019 and has held it in 29 quarters since.
  • Nuveen's Chemed position peaked at $41.3M in Q4 2020.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.